VENCO, ACHILLE
 Distribuzione geografica
Continente #
NA - Nord America 17.123
EU - Europa 13.080
AS - Asia 6.244
SA - Sud America 871
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 8
Totale 37.444
Nazione #
US - Stati Uniti d'America 16.961
IT - Italia 5.923
UA - Ucraina 2.425
SG - Singapore 1.837
TR - Turchia 1.354
SE - Svezia 1.287
CN - Cina 1.101
VN - Vietnam 889
DE - Germania 871
HK - Hong Kong 771
BR - Brasile 746
FI - Finlandia 683
IE - Irlanda 612
GB - Regno Unito 456
RU - Federazione Russa 320
FR - Francia 291
IN - India 99
MX - Messico 84
CA - Canada 61
JP - Giappone 55
AR - Argentina 49
PL - Polonia 40
BD - Bangladesh 37
ZA - Sudafrica 35
EU - Europa 34
BE - Belgio 27
ES - Italia 27
NL - Olanda 24
EC - Ecuador 17
IQ - Iraq 17
CZ - Repubblica Ceca 16
AT - Austria 15
MA - Marocco 15
CH - Svizzera 14
LT - Lituania 14
UZ - Uzbekistan 14
CO - Colombia 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 13
CL - Cile 10
AE - Emirati Arabi Uniti 9
CM - Camerun 9
KE - Kenya 9
PY - Paraguay 9
SA - Arabia Saudita 8
UY - Uruguay 7
EG - Egitto 6
AU - Australia 5
DK - Danimarca 5
NP - Nepal 5
RO - Romania 5
AL - Albania 4
AZ - Azerbaigian 4
PE - Perù 4
BB - Barbados 3
BO - Bolivia 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
JO - Giordania 2
MD - Moldavia 2
NO - Norvegia 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 37.444
Città #
Milan 4.481
Jacksonville 1.798
Fairfield 1.768
Chandler 1.411
Dallas 1.339
Ashburn 1.230
Singapore 1.008
Woodbridge 898
Hong Kong 767
Wilmington 762
Dearborn 694
Izmir 686
Cambridge 649
Seattle 631
Houston 630
Dublin 613
Princeton 600
Nyköping 525
Beijing 435
Ann Arbor 422
Dong Ket 382
Boardman 320
Rome 315
San Mateo 297
New York 194
The Dalles 184
San Diego 145
Los Angeles 129
Ogden 121
Munich 115
London 102
Chicago 100
Düsseldorf 91
Como 81
Santa Clara 72
Ho Chi Minh City 64
Mexico City 57
Helsinki 56
Hefei 55
Tokyo 54
Washington 54
São Paulo 52
Turku 48
Kunming 47
Des Moines 45
Nanjing 44
Norwalk 43
Hanoi 42
Verona 41
Frankfurt am Main 40
Warsaw 36
Kocaeli 35
Philadelphia 34
Buffalo 31
Jinan 28
Brussels 27
Orem 27
Johannesburg 26
Rio de Janeiro 26
Brooklyn 25
Guangzhou 25
Montreal 25
Stockholm 25
Berlin 23
Council Bluffs 22
San Francisco 22
Nanchang 21
Atlanta 20
Zhengzhou 20
Boston 19
Denver 19
Chennai 18
Phoenix 18
Shenyang 18
Poplar 17
Belo Horizonte 16
Pune 16
Toronto 16
Curitiba 15
Fuzhou 15
Redwood City 15
Stuttgart 15
Auburn Hills 14
Brno 13
Brasília 12
Columbus 12
Haiphong 11
Manchester 11
Nuremberg 11
Shanghai 11
Tashkent 11
Ankara 10
Changsha 10
Falls Church 10
Querétaro 10
Baotou 9
Chiswick 9
Chongqing 9
Porto Alegre 9
Amsterdam 8
Totale 25.642
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.135
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease 218
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study) 212
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 202
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 198
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 197
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 193
Venous and arterial thrombosis in patients with HIV infection 193
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study 188
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism. 186
Ambulatory blood pressure monitoring and atrial natriuretic peptide in normotensive and mild hypertensive subjects 185
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? 183
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality 182
Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan)in patients with diabetes and hypertension 181
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 181
24-hour blood pressare profile and left ventricular anatomy and function in untreated hypertensives with and without microalbuminuria 180
An unusual case presenting with hypertensive crisis. 178
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 176
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis 174
Statins, fibrates, and venous thromboembolism: a meta-analysis. 171
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays 170
JAK2 mutation and atypical chronic myeloid leukemia 168
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism. 167
Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: A randomized, controlled pilot study 167
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT 166
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 166
Treatment with enalapril modifies the pain perception pattern in hypertensive patients. 165
POST-PRANDIAL GLYCEMIA DOES NOT INFLUENCE LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN NON-DIABETIC ESSENTIAL HYPERTENSIVES 164
Relationship between a genetic predisposition to hypertension, blood pressure levels and pain sensitivity 164
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 162
Acute neutrophil count is a predictor of worst short and long-term outcome in spontaneous intracerebral haemorrhage. 162
ORAL VITAMIN K LOWERS THE INTERNATIONAL NORMALIZED RATIO MORE RAPIDLY THAN SUBCUTANEOUS VITAMIN K IN THE TREATMENT OF WARFARIN-ASSOCIATED COAGULOPATHY 161
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 161
Family history of hypertension hyperinsulinemia and left ventricular function in lean and obese hypertensives 161
Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives. 159
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. 159
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 157
24-hour non-invasive blood pressure monitoring and pain sensitivity 157
HOW MANY ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION CAN ACTUALLY BE TREATED WITH ORAL ANTICOAGULANTS? 156
Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect 156
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 156
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 156
Insulin sensitivity in obese normotensive adults: influence of family history of hypertension 155
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 155
Acute neutrophil count is a predictor of worst short-and long-term outcome in spontaneous intracerebral haemorrahge 155
“Patterns” di deposito di calico-fosforo nelle placche carotidee nell’uomo. 154
Isolated office hypertension: a 3 year follow-up study. 153
Circadian blood pressure variability is associated with autonomic and baroreflex-mediated modulation of the sinoatrial node 153
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 153
Left ventricular anatomy and function in „white coat“ hypertensives: comparison with normotensives and never-treated ambulatory hypertensives. 153
Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension. 153
Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly-diagnosed never-treated hypertensives. 153
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 153
OSA, metabolic syndrome and CPAP: Effect on cardiac remodeling in subjects with abdominal obesity. 152
Genetic predisposition to hypertension influences left ventricular changes during antihypertensive therapy 151
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 151
Abnormal response to handgrip in hypertensive patients with increased left ventricular mass, assessed by echocardiography. 151
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 150
Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection. 150
Mental stress test-induced changes in pain sensitivity and haemodynamic variables. 149
Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function 149
Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one year follow-up study. 149
Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. 149
Plasma matrix metalloproteinase (MMP)-9 and tissue inhibitor of MMPS (TIMP)-1 in hypertension: a meta-analysis. 148
AORTIC STIFFNESS IN NEVER - TREATED HYPERTENSIVES: LACK OF RELATION WITH MYOCARDIAL HYPERTROPHY AND IMPAIRED LEFT VENTRICULAR RELAXATION 147
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement 147
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 147
Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade 147
Ambulatory monitoring in hypertensive patients: correlation between the first three hour elevation and the nocturnal pressure fall. 147
Systematic Review: Neutrophils and Clinical Outcomes in Patients With Acute Coronary Syndromes and/or Cardiac Revascularization. 147
Natriuretic peptides as markers of preclinical cardiac disease in obesity 147
Relation of extent of nocturnal blood pressure decrease to cardiovascular remodeling in never-treated patients with essential hypertension. 146
The effect of thyroid autoantibodies on warfarin stability. 145
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia 144
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement. 144
Left ventricular anatomy and function in normotensive young adults with hypertensive parents: study at rest and during handgrip. 144
CD4+CD25+ regulatory T cell population in atherosclerosis: pharmacological modulation. 144
Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives. 144
Left ventricular changes induced by chronic treatment with ACE-inhibitors independently of blood pressure effects 143
Hyperinsulinemia, family history of hypertension and essential hypertension 142
Tumor necrosis factor-alpha and interleukin-4 production by circulating lymphocytes and interleukin-8 release by neutrophilis in patients with and without obstructive sleep apnea syndrome 142
Double-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function. 142
Association of cardiomyopathy with Kugelberg-Welander disease. 142
Endothelial cell dysfunction in patients with peripheral artery disease. 142
Systematic review: neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization. 142
Il trattamento con rosuvastatina è associato ad una riduzione dell’espressione del recettore di tipo 1, ma non di tipo 2, dell’Angiotensina II in monociti circolanti di pazienti diabetici. 142
Glycemic control in type 2 diabetes mellitus : relationship with left ventricular diastolic dysfunction and matrix metalloproteinases 142
Metabolic syndrome and morpho-functional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. 141
CHRONIC TREATMENT WITH ACE-INHIBITORS INDUCES LEFT VENTRICULAR CHANGES INDEPENDENTLY OF BLOOD PRESSURE DECREASE 140
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia 139
Aldosterone antagonist improves left ventricular diastolic function: a randomized, controlled study in essential hypertensives. 139
Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans. 139
Cytokine Production by Circulating Lymphocytes and Neutrophils in Patients with and without Obstructive Sleep Apnea Syndrome 139
Plasma measurement of d-dimer levels for the early diagnosis of ischemic stroke subtypes 139
Mixed cranial nerve neuroma revealing itself as baroreflex failure 138
Effetto del trattamento con simvastatina sulla funzione dei leucociti polimorfonucleati in soggetti ad alto rischio cardiovascolare 138
THE USE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: FROM CLINICAL TRIALS TO CLINICAL PRACTICE. 137
Patients with type 2 diabetes vs. non-diabetic high-risk subjects: effect of simvastatin on angiotensin II type 1 receptor mRNA expression in leukocytes 137
Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: a cross sectional study. 137
Left ventricular remodeling in patients with metabolic syndrome: Influence of gender. 137
Totale 16.731
Categoria #
all - tutte 145.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.910


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.792 0 0 0 0 0 507 83 352 643 163 354 690
2021/20223.129 266 458 309 241 157 45 143 193 182 448 270 417
2022/20233.589 378 186 213 438 281 851 1 459 542 82 74 84
2023/20246.945 1.161 1.057 1.197 1.325 1.252 540 32 74 185 33 28 61
2024/20253.937 25 54 754 97 118 238 152 264 390 305 323 1.217
2025/20264.866 722 775 1.054 1.370 738 207 0 0 0 0 0 0
Totale 37.542